CollPlant Biotechnologies Ltd.
CLGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,609 | -$7,019 | -$16,925 | $237 |
| Dep. & Amort. | $1,038 | $1,102 | $1,076 | $773 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,719 | $1,937 | $2,174 | $1,620 |
| Change in WC | -$262 | $1,001 | -$611 | $155 |
| Other Non-Cash | $21 | $216 | $588 | -$284 |
| Operating Cash Flow | -$14,093 | -$2,763 | -$13,698 | $2,501 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$483 | -$954 | -$1,274 | -$1,428 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$56 | -$202 | $30,196 | -$30,128 |
| Investing Cash Flow | -$539 | -$1,156 | $28,922 | -$31,556 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $1,108 | $1,874 | $38,760 |
| Financing Cash Flow | $9 | $1,108 | $1,874 | $38,760 |
| Forex Effect | -$142 | -$379 | -$608 | $143 |
| Net Chg. in Cash | -$14,765 | -$3,190 | $16,490 | $9,848 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,674 | $29,864 | $13,374 | $3,526 |
| End Cash | $11,909 | $26,674 | $29,864 | $13,374 |
| Free Cash Flow | -$14,576 | -$3,717 | -$14,972 | $1,073 |